Series B funding round for Remix Therapeutics raising $70M in May 2022
Series B funding round for Remix Therapeutics raising $70M in May 2022
| Investor | Firm Type | Partner |
|---|
Citadel LLCLEAD | Private | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Shane Neman | |
| Angel | Josh Resnick |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$271M
Top Valuation
-
Remix Therapeutics raised $70M in a Series B round.
The round was announced on 05/01/22.
The round was led by Surveyor Capital.